The emerging therapy of this peptide represents a major development in the handling of type 2 diabetes. Unlike existing drugs, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) and the GIP hormone https://tirzepatidepeptide783874.ltfblog.com/40410276/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment